Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
Recruiting now · Not applicable
Conditions studied: Severe Hypoglycemia, Type1diabetes
In brief
The GLUREDIA study investigates the counter-regulatory response (CRR) during hypoglycemia in children with type 1 diabetes (T1D). Hypoglycemia can lead to severe symptoms, but is normally counteracted by CRR, corresponding to the secretion of hormones to maintain normoglycemia. Hypoglycemia is common in T1DM but some patients develop severe hypoglycemia as a result of CRR dysfunction. Despite several studies in adults, the presence of CRR dysfunction remains unpredictable and not well understood. The objective of GLUREDIA is therefore to describe and predict the evolution of CRR in children with T1DM.
Key facts
- Study ID
- NCT06770621
- Run by
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- People needed
- 1000
- Starts
- 2022-05-25
- Expected to finish
- 2025-10-25
- Last updated by the study team
- 2025-01-13
Who can join
Age: 2 and older, up to 30. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clinique Universitaires Saint Luc — Brussels, Woluwe-saint-lambert, Belgium (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.